483
Glaxo Operations UK LimitedGlaxo Operations UK Limited – FDA 483, Sep 6, 2019
Record Details
During an inspection of Glaxo Operations UK Limited in Ware, Hertfordshire, the FDA observed a lack of established procedures to prevent objectionable microorganisms in non-sterile drug products. Specifically, there was no sanitization of critical water supply loops feeding manufacturing and active pharmaceutical ingredient suites. This indicates a significant concern regarding microbial control within the facility's production environment.
View Company Profile
ID · 2bef018f-36a5-45a3-a782-6a5cc2a5fe15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.